BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• BioMidwest

  Bruker Introduces Novel Point-of-Need Applied Mass Spectrometry Tools for Accelerated Measurements without Chromatography

  Recent acquisition of DART™ (Direct Analysis Real-time Technology) innovator IonSense extends Bruker’s unique Point-of-Need (PoN) mass spectrometers.

  June 6, 2022

   · 

  4 min read
• BioMidwest

  Abeona Therapeutics to Present at the Jefferies Healthcare Conference

  Abeona Therapeutics Inc. (Nasdaq: ABEO), a fully-integrated leader in cell and gene therapy, today announced that company management is scheduled to present at the Jefferies Healthcare Conference on Thursday, June 9, 2022, at 3:30 p.m. EDT.

  June 6, 2022

   · 

  3 min read
• BioMidwest

  ETHICON LAUNCHES NEXT GENERATION ECHELON™ 3000 STAPLER DESIGNED FOR EXCEPTIONAL ACCESS AND CONTROL

  Highly Anticipated Stapler Offers Greatest Articulation Span and Widest Jaw Aperture Among Leading Handheld Staplers.

  June 6, 2022

   · 

  9 min read
• Genetown

  2seventy bio to Participate in Goldman Sachs 43rd Annual Global Healthcare Conference

  2seventy bio to Participate in Goldman Sachs 43rd Annual Global Healthcare Conference.

  June 6, 2022

   · 

  1 min read
• BioMidwest

  Piezo Motion Launches High-Precision, Standing Wave-Type Line of Motors Ahead of the Energy, Drone & Robotics Summit

  Piezo Motion, a Brain Scientific company, announces the release of rotary motors for devices or applications requiring rapid response times, high-torque, micro-radian resolution and almost zero backlash.

  June 6, 2022

   · 

  5 min read
• Pharm Country

  Xalud Therapeutics CEO to Participate in Two Gene Therapy Focused Panels at BIO International Convention 2022

  Xalud Therapeutics, a clinical-stage biotechnology company developing novel non-viral gene therapies to treat pathologic inflammation, announced today that Chief Executive Officer Diem Nguyen, Ph.D., MBA, will participate in two panels at the BIO International Convention.

  June 6, 2022

   · 

  2 min read
• Drug Development

  Adicet Bio Reports Emerging Data from ADI-001 Phase 1 Trial at the American Society of Clinical Oncology Annual Meeting

  ADI-001 demonstrated 75% CR and ORR rate across all dose levels with favorable safety and tolerability profile in patients with relapsed/refractory high grade aggressive Non-Hodgkin’s Lymphoma (NHL), as of May 31, 2022 data-cut date.

  June 6, 2022

   · 

  13 min read
• Genetown

  Vizgen Showcases Expansion of MERSCOPE™ In Situ Single-Cell Spatial Genomics Platform Capabilities at AGBT

  Vizgen Showcases Expansion of MERSCOPE™ In Situ Single-Cell Spatial Genomics Platform Capabilities at AGBT.

  June 6, 2022

   · 

  5 min read
• Drug Development

  Praxis Precision Medicines Reports Negative Results from PRAX-114 Phase 2/3 Monotherapy Aria Study in Patients with Major Depressive Disorder

  Aria Study did not achieve statistical significance on the primary endpoint Strategic realignment to focus resources on Movement Disorders and Epilepsy franchises extends cash runway into 2024.

  June 6, 2022

   · 

  3 min read
• Deals

  BD TO ACQUIRE PARATA SYSTEMS TO ENTER NEW PHARMACY AUTOMATION SOLUTIONS MARKET

  Expands BD Transformative Solutions to Provide New Pharmacy Automation Technologies for Hospitals, Retail Pharmacy, Long-Term Care and Home Settings.

  June 6, 2022

   · 

  7 min read